Google_site External News
Life Sciences & Pharma Articles
Google_site External News
Brokers' take: CGS-CIMB initiates 'add' on Hyphens Pharma with S$0.36 target price - The Business Times
Industry News External News
Want to study medicine and be a doctor in Singapore? Here’s what you need to know - CNA
Industry News External News
Trump’s tariffs on imported drugs ‘not a big concern’ for China’s pharma firms - South China Morning Post
Google News – Cardiology External News
Sun Pharma, AstraZeneca in distribution pact for heart drug - Moneycontrol.com
Google News – Oncology External News
Jazz to withdraw Zepzelca with FDA in second-line small cell lung cancer - Fierce Pharma
Google News – Oncology External News
AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal - Fierce Pharma
Google News – Oncology External News
As Akeso takes center stage at ASCO, China biotech industry cements its coming of age - Fierce Pharma
Google News – Oncology External News
2MM: Pharma Roundup – Pfizer’s $10.5B Innovent oncology partnership, Guselkumab (Tremfya) gains a broader psoriatic arthritis label, Venetoclax (Venclyxto) expands first-line CLL options, and Seladelpar (Livdelzi) advances in primary biliary cholangitis - 2 Minute Medicine
Google News – EMA (biotech/pharma) External News
EU Pharma Package: ‘Give Patients Top EMA Committee Voting Rights’ - insights.citeline.com
Google News – EMA (biotech/pharma) External News
EMA’s CHMP backs two novel medicines approvals - The Pharma Letter
Google News – EMA (biotech/pharma) External News
Wockhardt WCK 5222 granted accelerated assessment by EMA - Medical Dialogues
Google News – EMA (biotech/pharma) External News
'Sharp rise' in illegal obesity drugs, Europe warns - Fierce Pharma
Google News – FDA (biotech/pharma) External News
FDA extends Beren’s rare disease review after info request, further stretching saga - Fierce Biotech
Google News – FDA (biotech/pharma) External News